Unterehmen auf Watchlist setzen
Elanco Animal Health
ISIN: US28414H1032
WKN: A2N6BH
Über
Unternehmensprofil
Tipp: Investor-Alerts aktivieren
Lassen Sie sich bei neuen Publikationen informieren
Tipp: AI-Factsheet

Corporate News meets AI! 
Analyse der Inhalte und Zusammenfassung

Elanco Animal Health · ISIN: US28414H1032 · PR Newswire (ID: 20240707DC54501)
07 Juli 2024 04:45PM

ELAN Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Elanco Animal Health Incorporated (NYSE: ELAN) Investors with Significant Losses to Contact the Firm


RADNOR, Pa., July 7, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Elanco Animal Health Incorporated (NYSE: ELAN) ("Elanco").

On June 27, 2024, Elanco issued a press release providing updates to the company's expected FDA approval timelines for its animal disease treatments, Zenrelia and Credelio Quattro. In the release, Elanco stated that Zenrelia is expected to receive FDA approval in the third quarter of 2024, leading to a potential commercial launch in the fourth quarter of 2024, despite the company having previously set a launch timeline for the third quarter of 2024. Elanco also stated that Credelio Quattro is expected to receive FDA approval in the fourth quarter of 2024, despite having previously set an approval timeline for the third quarter of 2024.

On this news, Elanco's stock price fell $3.69 per share, or 20.53%, to close at $14.28 per share on June 27, 2024.

If you are an Elanco investor and would like to learn more about our investigation, please CLICK HERE to fill out our online form or contact Kessler Topaz Meltzer & Check, LLPJonathan Naji, Esq. (484) 270-1453 or E-mail at info@ktmc.com. You can also click on the following link or paste it in your browser:  https://www.ktmc.com/elanco-animal-health-incorporated-investigation?utm_source=PR&utm_medium=link&utm_campaign=elan&mktm=r 

Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and other violations of state and federal law. Kessler Topaz Meltzer & Check, LLP is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world.  The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars).  For more information Kessler Topaz Meltzer & Check, LLP, please visit www.ktmc.com.  

CONTACT:

Kessler Topaz Meltzer & Check, LLP

Jonathan Naji, Esq.

280 King of Prussia Road

Radnor, PA 19087

(484) 270-1453

info@ktmc.com

May be considered attorney advertising in certain jurisdictions.  Past results do not guarantee future outcomes.

Cision View original content:https://www.prnewswire.com/news-releases/elan-investigation-reminder--kessler-topaz-meltzer--check-llp-encourages-elanco-animal-health-incorporated-nyse-elan-investors-with-significant-losses-to-contact-the-firm-302189212.html

SOURCE Kessler Topaz Meltzer & Check, LLP

Visuelle Wertentwicklung / Kursverlauf · Elanco Animal Health
Smarte Analyse- und Recherchewerkzeuge finden Sie hier.
This publication was provided by our content partner PR Newswire
PR Newswire
via PR Newswire - Newsfeed
Cision ©2025
PR Newswire
Kontakt:
300 S Riverside Plaza, Chicago, Illinois, USA
+001 (0) 888-776-0942